New study questions benefits of GLP-1 drugs for weight loss, finding high costs with little long-term health benefit. Read ...

According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the ...

The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as ...

Semaglutide, the active ingredient found in Ozempic and Wegovy, may reduce the risk of Alzheimer’s disease, a new study published Thursday morning finds.

Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...

A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...

Eli Lilly (LLY) is reportedly preparing to launch Mounjaro in Denmark, the home country of its leading rival in the ...

Weight-loss jabs are not a quick fix for an “Instagram body”, the Health Secretary has warned. The medicines regulator has ...

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...